On a mission to collect a key Crohn’s disease approval and build out its inflammatory bowel disease (IBD) profile, Eli Lilly ...
In win for compounders, FDA will review its decision to put Eli Lilly's tirzepatide on shortage list
In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...
Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena ...
All the companies have skin in the game for clotting/bleeding disorders. The BMS-Pfizer Alliance market Factor Xa blood ...
Earlier this year, Evonik unveiled a restructuring project that will result in up to 2,000 layoffs. | After Evonik in March ...
In less than a month, Americans will head to the polls—or vote by mail—and elect the next president of the U.S. | While a ...
Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...
A new campaign from Opella, Sanofi’s consumer health unit, is a royal flush. | A new campaign from Opella, Sanofi’s consumer ...
A year after Pinterest first began allowing advertisements from prescription drugmakers and prescribers, Publicis Health Media has accumulated several tips and tricks for pharmas seeking success on ...
Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...
Thermo Fisher plant in North Carolina flagged for contamination, air bubble issues in FDA inspection
Thermo Fisher Scientific is responsible for helping to produce some of the hottest drugs on the market, including Novo ...
With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback